366 related articles for article (PubMed ID: 16802556)
1. [Mesenchymal stem cells for cardiac regeneration].
Krausgrill B; Schwinger RH; Müller-Ehmsen J
Med Klin (Munich); 2006 Mar; 101 Suppl 1():202-6. PubMed ID: 16802556
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection and cardiac regeneration by mesenchymal stem cells.
Schäfer R; Northoff H
Panminerva Med; 2008 Mar; 50(1):31-9. PubMed ID: 18427386
[TBL] [Abstract][Full Text] [Related]
3. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS
J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008
[TBL] [Abstract][Full Text] [Related]
4. Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model.
Derval N; Barandon L; Dufourcq P; Leroux L; Lamazière JM; Daret D; Couffinhal T; Duplàa C
Eur J Cardiothorac Surg; 2008 Aug; 34(2):248-54. PubMed ID: 18457957
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.
Kajstura J; Rota M; Whang B; Cascapera S; Hosoda T; Bearzi C; Nurzynska D; Kasahara H; Zias E; Bonafé M; Nadal-Ginard B; Torella D; Nascimbene A; Quaini F; Urbanek K; Leri A; Anversa P
Circ Res; 2005 Jan; 96(1):127-37. PubMed ID: 15569828
[TBL] [Abstract][Full Text] [Related]
6. [Electrophysiological properties of stem cells].
Ravens U
Herz; 2006 Apr; 31(2):123-6. PubMed ID: 16738835
[TBL] [Abstract][Full Text] [Related]
7. [The therapeutic effect of autologous bone marrow cells in ischemic heart disease].
Hristov M; Keymel S; Weber C
Med Klin (Munich); 2006 Mar; 101 Suppl 1():186-9. PubMed ID: 16802551
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
[TBL] [Abstract][Full Text] [Related]
9. [Mesenchymal stem cell transplantation for myocardial reparation of rat experimental heart failure].
Krugliakov PV; Sokolova IB; Amineva KhK; Nekrasova NN; Viĭde SV; Cherednichenko NN; Zaritskiĭ AIu; Semernin EN; Kisliakova TV; Polyntsev DG
Tsitologiia; 2004; 46(12):1043-54. PubMed ID: 15747834
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac cell therapy: the puzzle is waiting to be solved].
Canepa M; Coviello D; Chiarella F
G Ital Cardiol (Rome); 2006 Apr; 7(4):252-65. PubMed ID: 16700408
[TBL] [Abstract][Full Text] [Related]
11. Advances in cell-based therapy for structural heart disease.
Mazhari R; Hare JM
Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519
[TBL] [Abstract][Full Text] [Related]
12. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms.
Xu RX; Chen X; Chen JH; Han Y; Han BM
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):176-80. PubMed ID: 18785984
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
[TBL] [Abstract][Full Text] [Related]
15. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.
Boomsma RA; Swaminathan PD; Geenen DL
Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
[TBL] [Abstract][Full Text] [Related]
17. Neovascularization and cardiac repair by bone marrow-derived stem cells.
Badorff C; Dimmeler S
Handb Exp Pharmacol; 2006; (174):283-98. PubMed ID: 16370332
[TBL] [Abstract][Full Text] [Related]
18. [Stem cells and cardiac regeneration].
Perez Millan MI; Lorenti A
Medicina (B Aires); 2006; 66(6):574-82. PubMed ID: 17240634
[TBL] [Abstract][Full Text] [Related]
19. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.
Hu X; Wang J; Chen J; Luo R; He A; Xie X; Li J
Eur J Cardiothorac Surg; 2007 Mar; 31(3):438-43. PubMed ID: 17239611
[TBL] [Abstract][Full Text] [Related]
20. Myocardial regeneration: the role of progenitor cells derived from bone marrow and heart.
Wang X; From AH; Zhang J
Prog Mol Biol Transl Sci; 2012; 111():195-215. PubMed ID: 22917232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
